Mytesi
Payments companies reported to CMS as associated with Mytesi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mytesi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mytesi
These are the largest totals companies reported as associated with Mytesi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Andrew Mulberg | Camden, NJ | Pediatrics | $64,585.40 |
| Robin Beach | Houston, TX | Family | $56,409.69 |
| Sandra Swain | Bethesda, MD | Hematology & Oncology | $49,136.27 |
| Eric Roeland | Portland, OR | Hospice and Palliative Medicine (Internal Medicine) | $36,144.97 |
| Elie Schochet | Ft Lauderdale, FL | Colon & Rectal Surgery | $35,536.13 |
| Lee Schwartzberg | Reno, NV | Medical Oncology | $35,362.33 |
| Hope Rugo | San Francisco, CA | Hematology (Internal Medicine) | $33,466.67 |
| Corey Siegel | Lebanon, NH | Gastroenterology (Internal Medicine) | $30,000.00 |
| David Asmuth | Sacramento, CA | Infectious Disease | $27,000.00 |
| Pablo Okhuysen | Houston, TX | Infectious Disease | $24,432.27 |
Prescribed Mytesi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.